-
1 Comment
Wenzhou Kangning Hospital Co., Ltd is currently in a long term uptrend where the price is trading 71.1% above its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Wenzhou Kangning Hospital Co., Ltd's total revenue sank by 3.5% to $465M since the same quarter in the previous year.
Its net income has increased by 596.8% to $36M since the same quarter in the previous year.
Finally, its free cash flow grew by 141.2% to $30M since the same quarter in the previous year.
Based on the above factors, Wenzhou Kangning Hospital Co., Ltd gets an overall score of 4/5.
| ISIN | CNE100002383 |
|---|---|
| Exchange | HK |
| CurrencyCode | HKD |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Dividend Yield | 6.6% |
|---|---|
| Beta | -0.09 |
| PE Ratio | 9.71 |
| Market Cap | 667M |
| Target Price | 25.83 |
Wenzhou Kangning Hospital Co., Ltd., together with its subsidiaries, operates a network of healthcare facilities in the People's Republic of China. The company provides psychiatric specialty care and elderly rehabilitation services. It is also involved in property leasing and management; provision of hospital management, medical services, technology, and nursing care services; drug retail and pharmaceutical retail; and equity investments activities. The company was formerly known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital and changed its name to Wenzhou Kangning Hospital Co., Ltd. in October 2014. Wenzhou Kangning Hospital Co., Ltd. was founded in 1996 and is headquartered in Wenzhou, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2120.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
